Gefitinib

Gefitinib

Gefitinib

Min.Order / FOB Price:Get Latest Price

10 Gram

Negotiable

  • Min.Order :10 Gram
  • Purity: 99%
  • Payment Terms : L/C,D/P,T/T,Other

Keywords

anti-cancer pharmaceutical Gefitinib CAS 184475-35-2 High purity Gefitinib CAS 184475-35-2 High quality IRESSA 99%/Gefitinib 99% by HPLC CAS:184475-35-2 with competitive price and best service

Quick Details

  • Appearance:white powder
  • Application:Gefitinib is an EGFR (epidermal growth factor receptor)-tyrosine kinase inhibitor and has been shown to increase phosphorylation of c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein ki
  • PackAge:For small quantity: Bag Commercial quantity: fiber drum Or as per customers required
  • ProductionCapacity:10|Kilogram|Month
  • Storage:Store at RT
  • Transportation:air or ocean or rail or parcel post

Superiority:

SUNSANTA
  We are one of the leading exporters in China in the fields of active pharma
ingredients including oncology drug, prostaglandin, anti-HIV drug, cardiovascular
drug, diabetes drug, anti-inflammatory drug, urinary system drug, cosmetics peptide
and intermediate, dyestuff & pigment and kinds of package materials. 
  We specialize in synthesis of novel organic compounds, process development
and manufacturing of pharmaceutical and fine organic chemicals from gram to kilogram quantity.
  We supply
1.in very competitive price;
2.Quality Guaranteed;
3.Fast Delivery;
4.Payment:L/C;D/P;TT;;Paypal.
5.On-time shipment and pre-shipment product quality safeguards.
 

Details:

Specifications 

  Gefitinib is an EGFR (epidermal growth factor receptor)-tyrosine kinase inhibitor .

1   Specification

 

 

Gefitinib CAS 184475-35-2 Brand: SUNSANTA
MW:446.9 MSDS: Avaiable
MF:C22H24ClFN4O3 Sample: Avaiable
Category: API Min order: 10grams
Quality standard: 99.50% Purity Place of Origin:China
Usage: Gefitinib is an EGFR (epidermal growth factor receptor)-tyrosine kinase inhibitor and has been shown to increase phosphorylation of c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in HaCaT cells. Studies suggest that Gefitinib can enhance keratinocyte apoptosis via an EGFR-independent JNK-activation pathway. Research indicates that Gefitinib can induce apoptosis in several cell lines including, HaCaT cells, KG-1, P39, and primary CD34+ myeloblasts. Erlotinib (sc-202154) has similar properties to Gefitinib.
Applications Pharmaceutical raw materials

 

2   Quality Specification  

   Contact SUNSANTA  for updated version COA

3   Package details

   For small quantity: Bag  Commercial quantity: fiber drum  Or as per customers required

 

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View